Perth-based biotechnology companies Avicena Systems and Syngenis Laboratories are partnering to accelerate development and high-volume deployment of pathogen detection technology, according to multiple reports. The companies say the effort is aimed at strengthening Australia’s biosecurity capability by improving detection of pathogens that could affect public health, domestic agriculture and trade.
All sources describe the project as a collaboration between the two firms, focused on scaling up detection tools rather than only early research. The technology is presented as a “biosecurity shield,” reflecting its intended role in helping detect potential biological threats more quickly and at scale. While the articles do not provide technical specifics or named customers, they consistently link the partnership to the protection of health systems, agricultural production and Australia’s trading position.
Overall, the reporting frames the partnership as an attempt to move pathogen detection from development to broader operational use, with the stated goal of enhancing national resilience to biosecurity risks.
